FDA Outsourcing Facility User Fee Rates: Fiscal Year 2019

August 13, 2018

FDA 2019 Outsourcing Facility User Fee Rates

According to a recently released notice from the FDA, “the FD&C Act authorizes FDA to assess and collect an annual establishment fee from outsourcing facilities, as well as a re-inspection fee for each re-inspection of an outsourcing facility.” Fees increased slightly between FY 2018 and FY 2019. These updated fee rates will be effective October 1, 2018 through September 30, 2019.

The new user fee rates are as follows:

Fee Category FY 2019 Fee Rates FY 2018 Fee Rates
Qualified Small Business Establishment Fee $5,461 $5,364
Non-Small Business Establishment Fee $18,375 $17,364
Re-inspection Fee $16,382 $16,093


We are qualified and have helped many facilities with the FDA registration process in the past. Contact us today to learn more about how we can help your facility register and reduce the total cost to do so.

Agency Alerts General Regulatory

August 2, 2016

FDA Prescription Drug User Fee Rates: Fiscal Year 2017

The Prescription Drug User Fee Amendments of 2012 (PDUFA V) allows FDA to collect user fees for the review of applications concerning human drug and biological products, the establishments where...

Read the Full Article
Agency Alerts General Regulatory

August 5, 2016

FDA Outsourcing Facility Fee Rate: Fiscal Year 2017

According to section 503B(d)(4) of the Federal Food, Drug, and Cosmetic (FD&C) an outsourcing facility is “a facility at one geographic location or address that is engaged in the compounding of...

Read the Full Article
Agency Alerts

August 8, 2018

FDA Biosimilar User Fee Rates: Fiscal Year 2019

On Tuesday, July 31st, FDA released a notice with updated biosimilar user fee rates for fiscal year 2019. The base revenue for FY 2019 is $40,214,000, not adjusted for inflation or operating...

Read the Full Article